nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—Aprindine—Amitriptyline—migraine	0.185	0.555	CrCrCtD
Fentanyl—Propafenone—Propranolol—migraine	0.0954	0.287	CrCrCtD
Fentanyl—OPRD1—Amitriptyline—migraine	0.0796	0.167	CbGbCtD
Fentanyl—OPRK1—Amitriptyline—migraine	0.0666	0.14	CbGbCtD
Fentanyl—OPRM1—Amitriptyline—migraine	0.0587	0.123	CbGbCtD
Fentanyl—Diphenhydramine—Amitriptyline—migraine	0.0523	0.157	CrCrCtD
Fentanyl—CYP3A7—Propranolol—migraine	0.0306	0.0643	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Propranolol—migraine	0.0306	0.0643	CbGbCtD
Fentanyl—CYP3A5—Propranolol—migraine	0.0229	0.0482	CbGbCtD
Fentanyl—CYP3A7—Verapamil—migraine	0.021	0.0441	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Verapamil—migraine	0.021	0.0441	CbGbCtD
Fentanyl—CYP3A5—Amitriptyline—migraine	0.0198	0.0417	CbGbCtD
Fentanyl—CYP3A5—Valproic Acid—migraine	0.0181	0.038	CbGbCtD
Fentanyl—ABCB1—Timolol—migraine	0.0167	0.0352	CbGbCtD
Fentanyl—CYP3A5—Verapamil—migraine	0.0157	0.0331	CbGbCtD
Fentanyl—ABCB1—Propranolol—migraine	0.0149	0.0314	CbGbCtD
Fentanyl—ABCB1—Amitriptyline—migraine	0.0129	0.0271	CbGbCtD
Fentanyl—ABCB1—Verapamil—migraine	0.0102	0.0215	CbGbCtD
Fentanyl—CYP3A4—Propranolol—migraine	0.00894	0.0188	CbGbCtD
Fentanyl—CYP3A4—Amitriptyline—migraine	0.00773	0.0163	CbGbCtD
Fentanyl—CYP3A4—Valproic Acid—migraine	0.00705	0.0148	CbGbCtD
Fentanyl—CYP3A4—Topiramate—migraine	0.00636	0.0134	CbGbCtD
Fentanyl—CYP3A4—Verapamil—migraine	0.00614	0.0129	CbGbCtD
Fentanyl—Bepridil—CACNA1A—migraine	0.000988	0.26	CrCbGaD
Fentanyl—Loperamide—CACNA1A—migraine	0.000875	0.23	CrCbGaD
Fentanyl—Alverine—HTR1A—migraine	0.000515	0.135	CrCbGaD
Fentanyl—Benazepril—MTHFR—migraine	0.000424	0.111	CrCbGaD
Fentanyl—Quinapril—ACE—migraine	0.000397	0.104	CrCbGaD
Fentanyl—Benazepril—ACE—migraine	0.000346	0.0909	CrCbGaD
Fentanyl—Methadone—HTR3A—migraine	0.000259	0.068	CrCbGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000112	0.00822	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—TAC1—migraine	0.000111	0.00814	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—NPS—migraine	0.000111	0.00814	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—EDNRA—migraine	0.000106	0.00776	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000105	0.00775	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000104	0.00764	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CALCRL—migraine	0.0001	0.00738	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—RAMP1—migraine	0.0001	0.00738	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—HTR1B—migraine	9.84e-05	0.00724	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR1D—migraine	9.84e-05	0.00724	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—TAC1—migraine	9.7e-05	0.00714	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—NPS—migraine	9.7e-05	0.00714	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	9.57e-05	0.00704	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—HTR1A—migraine	9.48e-05	0.00697	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—EDNRA—migraine	9.25e-05	0.00681	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR2B—migraine	9.15e-05	0.00673	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.14e-05	0.00672	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	8.9e-05	0.00655	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.79e-05	0.00647	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—HTR1B—migraine	8.63e-05	0.00635	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR1D—migraine	8.63e-05	0.00635	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.49e-05	0.00625	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—HTR1A—migraine	8.31e-05	0.00611	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.26e-05	0.00608	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—TAC1—migraine	8.2e-05	0.00603	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—NPS—migraine	8.2e-05	0.00603	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR2B—migraine	8.02e-05	0.0059	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.01e-05	0.00589	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.83e-05	0.00576	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—EDNRA—migraine	7.82e-05	0.00575	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	7.71e-05	0.00567	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CALCRL—migraine	7.65e-05	0.00563	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—RAMP1—migraine	7.65e-05	0.00563	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.53e-05	0.00554	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.45e-05	0.00548	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.44e-05	0.00547	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.42e-05	0.00546	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.42e-05	0.00546	CbGpPWpGaD
Fentanyl—Flatulence—Gabapentin—migraine	7.34e-05	0.00042	CcSEcCtD
Fentanyl—Anaphylactic shock—Valproic Acid—migraine	7.33e-05	0.00042	CcSEcCtD
Fentanyl—Oedema—Valproic Acid—migraine	7.33e-05	0.00042	CcSEcCtD
Fentanyl—Bradycardia—Topiramate—migraine	7.33e-05	0.000419	CcSEcCtD
Fentanyl—Pruritus—Verapamil—migraine	7.32e-05	0.000419	CcSEcCtD
Fentanyl—Tension—Gabapentin—migraine	7.31e-05	0.000418	CcSEcCtD
Fentanyl—OPRM1—G alpha (i) signalling events—HTR1B—migraine	7.3e-05	0.00537	CbGpPWpGaD
Fentanyl—Dysgeusia—Gabapentin—migraine	7.3e-05	0.000418	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—HTR1D—migraine	7.29e-05	0.00536	CbGpPWpGaD
Fentanyl—Infection—Valproic Acid—migraine	7.29e-05	0.000417	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.28e-05	0.00535	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.25e-05	0.00533	CbGpPWpGaD
Fentanyl—Haemoglobin—Topiramate—migraine	7.24e-05	0.000414	CcSEcCtD
Fentanyl—Nervousness—Gabapentin—migraine	7.24e-05	0.000414	CcSEcCtD
Fentanyl—Rhinitis—Topiramate—migraine	7.22e-05	0.000413	CcSEcCtD
Fentanyl—Back pain—Gabapentin—migraine	7.21e-05	0.000412	CcSEcCtD
Fentanyl—Haemorrhage—Topiramate—migraine	7.2e-05	0.000412	CcSEcCtD
Fentanyl—Nervous system disorder—Valproic Acid—migraine	7.19e-05	0.000412	CcSEcCtD
Fentanyl—Vertigo—Timolol—migraine	7.19e-05	0.000411	CcSEcCtD
Fentanyl—Thrombocytopenia—Valproic Acid—migraine	7.18e-05	0.000411	CcSEcCtD
Fentanyl—Syncope—Timolol—migraine	7.17e-05	0.000411	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—FOS—migraine	7.17e-05	0.00528	CbGpPWpGaD
Fentanyl—Hypoaesthesia—Topiramate—migraine	7.16e-05	0.00041	CcSEcCtD
Fentanyl—Hallucination—Topiramate—migraine	7.16e-05	0.00041	CcSEcCtD
Fentanyl—Muscle spasms—Gabapentin—migraine	7.16e-05	0.00041	CcSEcCtD
Fentanyl—Tachycardia—Valproic Acid—migraine	7.16e-05	0.00041	CcSEcCtD
Fentanyl—Vomiting—Propranolol—migraine	7.15e-05	0.000409	CcSEcCtD
Fentanyl—Pharyngitis—Topiramate—migraine	7.15e-05	0.000409	CcSEcCtD
Fentanyl—Skin disorder—Valproic Acid—migraine	7.12e-05	0.000408	CcSEcCtD
Fentanyl—Urinary tract disorder—Topiramate—migraine	7.11e-05	0.000407	CcSEcCtD
Fentanyl—Oedema peripheral—Topiramate—migraine	7.09e-05	0.000406	CcSEcCtD
Fentanyl—Hyperhidrosis—Valproic Acid—migraine	7.09e-05	0.000406	CcSEcCtD
Fentanyl—Rash—Propranolol—migraine	7.09e-05	0.000406	CcSEcCtD
Fentanyl—Dermatitis—Propranolol—migraine	7.08e-05	0.000405	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.08e-05	0.00521	CbGpPWpGaD
Fentanyl—Diarrhoea—Verapamil—migraine	7.08e-05	0.000405	CcSEcCtD
Fentanyl—Connective tissue disorder—Topiramate—migraine	7.08e-05	0.000405	CcSEcCtD
Fentanyl—Palpitations—Timolol—migraine	7.07e-05	0.000405	CcSEcCtD
Fentanyl—Urethral disorder—Topiramate—migraine	7.06e-05	0.000404	CcSEcCtD
Fentanyl—Loss of consciousness—Timolol—migraine	7.03e-05	0.000402	CcSEcCtD
Fentanyl—OPRM1—G alpha (i) signalling events—HTR1A—migraine	7.02e-05	0.00517	CbGpPWpGaD
Fentanyl—Vision blurred—Gabapentin—migraine	7.02e-05	0.000402	CcSEcCtD
Fentanyl—Anorexia—Valproic Acid—migraine	6.99e-05	0.0004	CcSEcCtD
Fentanyl—Cough—Timolol—migraine	6.98e-05	0.0004	CcSEcCtD
Fentanyl—Tremor—Gabapentin—migraine	6.98e-05	0.000399	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—CALCRL—migraine	6.95e-05	0.00511	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—RAMP1—migraine	6.95e-05	0.00511	CbGpPWpGaD
Fentanyl—Visual impairment—Topiramate—migraine	6.94e-05	0.000397	CcSEcCtD
Fentanyl—Ill-defined disorder—Gabapentin—migraine	6.91e-05	0.000396	CcSEcCtD
Fentanyl—Hypertension—Timolol—migraine	6.91e-05	0.000395	CcSEcCtD
Fentanyl—Anaemia—Gabapentin—migraine	6.89e-05	0.000394	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6.86e-05	0.00505	CbGpPWpGaD
Fentanyl—Hypotension—Valproic Acid—migraine	6.85e-05	0.000392	CcSEcCtD
Fentanyl—Agitation—Gabapentin—migraine	6.85e-05	0.000392	CcSEcCtD
Fentanyl—Dizziness—Verapamil—migraine	6.84e-05	0.000391	CcSEcCtD
Fentanyl—Myalgia—Timolol—migraine	6.81e-05	0.00039	CcSEcCtD
Fentanyl—Chest pain—Timolol—migraine	6.81e-05	0.00039	CcSEcCtD
Fentanyl—Arthralgia—Timolol—migraine	6.81e-05	0.00039	CcSEcCtD
Fentanyl—Erythema multiforme—Topiramate—migraine	6.81e-05	0.00039	CcSEcCtD
Fentanyl—Anxiety—Timolol—migraine	6.79e-05	0.000388	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—HTR2B—migraine	6.78e-05	0.00499	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.77e-05	0.00498	CbGpPWpGaD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	6.76e-05	0.000387	CcSEcCtD
Fentanyl—Discomfort—Timolol—migraine	6.73e-05	0.000385	CcSEcCtD
Fentanyl—Eye disorder—Topiramate—migraine	6.73e-05	0.000385	CcSEcCtD
Fentanyl—Malaise—Gabapentin—migraine	6.72e-05	0.000384	CcSEcCtD
Fentanyl—Tinnitus—Topiramate—migraine	6.71e-05	0.000384	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—RAMP1—migraine	6.71e-05	0.00494	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CALCRL—migraine	6.71e-05	0.00494	CbGpPWpGaD
Fentanyl—Vertigo—Gabapentin—migraine	6.69e-05	0.000383	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Valproic Acid—migraine	6.68e-05	0.000382	CcSEcCtD
Fentanyl—Cardiac disorder—Topiramate—migraine	6.68e-05	0.000382	CcSEcCtD
Fentanyl—Flushing—Topiramate—migraine	6.68e-05	0.000382	CcSEcCtD
Fentanyl—Syncope—Gabapentin—migraine	6.68e-05	0.000382	CcSEcCtD
Fentanyl—Nausea—Propranolol—migraine	6.68e-05	0.000382	CcSEcCtD
Fentanyl—Leukopenia—Gabapentin—migraine	6.67e-05	0.000382	CcSEcCtD
Fentanyl—Dry mouth—Timolol—migraine	6.66e-05	0.000381	CcSEcCtD
Fentanyl—Insomnia—Valproic Acid—migraine	6.63e-05	0.00038	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	6.61e-05	0.00486	CbGpPWpGaD
Fentanyl—Paraesthesia—Valproic Acid—migraine	6.59e-05	0.000377	CcSEcCtD
Fentanyl—Palpitations—Gabapentin—migraine	6.58e-05	0.000377	CcSEcCtD
Fentanyl—Confusional state—Timolol—migraine	6.58e-05	0.000377	CcSEcCtD
Fentanyl—Vomiting—Verapamil—migraine	6.58e-05	0.000376	CcSEcCtD
Fentanyl—Loss of consciousness—Gabapentin—migraine	6.55e-05	0.000375	CcSEcCtD
Fentanyl—Dyspnoea—Valproic Acid—migraine	6.54e-05	0.000374	CcSEcCtD
Fentanyl—Angiopathy—Topiramate—migraine	6.53e-05	0.000374	CcSEcCtD
Fentanyl—Oedema—Timolol—migraine	6.53e-05	0.000374	CcSEcCtD
Fentanyl—Anaphylactic shock—Timolol—migraine	6.53e-05	0.000374	CcSEcCtD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.52e-05	0.0048	CbGpPWpGaD
Fentanyl—Rash—Verapamil—migraine	6.52e-05	0.000373	CcSEcCtD
Fentanyl—Somnolence—Valproic Acid—migraine	6.52e-05	0.000373	CcSEcCtD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.52e-05	0.00479	CbGpPWpGaD
Fentanyl—Dermatitis—Verapamil—migraine	6.52e-05	0.000373	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.51e-05	0.00479	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.51e-05	0.00479	CbGpPWpGaD
Fentanyl—Immune system disorder—Topiramate—migraine	6.5e-05	0.000372	CcSEcCtD
Fentanyl—Cough—Gabapentin—migraine	6.5e-05	0.000372	CcSEcCtD
Fentanyl—Mediastinal disorder—Topiramate—migraine	6.49e-05	0.000371	CcSEcCtD
Fentanyl—Infection—Timolol—migraine	6.49e-05	0.000371	CcSEcCtD
Fentanyl—Headache—Verapamil—migraine	6.48e-05	0.000371	CcSEcCtD
Fentanyl—Chills—Topiramate—migraine	6.46e-05	0.00037	CcSEcCtD
Fentanyl—Dyspepsia—Valproic Acid—migraine	6.46e-05	0.000369	CcSEcCtD
Fentanyl—Convulsion—Gabapentin—migraine	6.46e-05	0.000369	CcSEcCtD
Fentanyl—Hypertension—Gabapentin—migraine	6.43e-05	0.000368	CcSEcCtD
Fentanyl—Shock—Timolol—migraine	6.42e-05	0.000368	CcSEcCtD
Fentanyl—Nervous system disorder—Timolol—migraine	6.4e-05	0.000366	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.38e-05	0.00469	CbGpPWpGaD
Fentanyl—Decreased appetite—Valproic Acid—migraine	6.38e-05	0.000365	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.37e-05	0.00469	CbGpPWpGaD
Fentanyl—Alopecia—Topiramate—migraine	6.36e-05	0.000364	CcSEcCtD
Fentanyl—Myalgia—Gabapentin—migraine	6.34e-05	0.000363	CcSEcCtD
Fentanyl—Chest pain—Gabapentin—migraine	6.34e-05	0.000363	CcSEcCtD
Fentanyl—Arthralgia—Gabapentin—migraine	6.34e-05	0.000363	CcSEcCtD
Fentanyl—Skin disorder—Timolol—migraine	6.34e-05	0.000363	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Valproic Acid—migraine	6.33e-05	0.000362	CcSEcCtD
Fentanyl—Fatigue—Valproic Acid—migraine	6.32e-05	0.000362	CcSEcCtD
Fentanyl—Anxiety—Gabapentin—migraine	6.32e-05	0.000362	CcSEcCtD
Fentanyl—Hyperhidrosis—Timolol—migraine	6.31e-05	0.000361	CcSEcCtD
Fentanyl—Mental disorder—Topiramate—migraine	6.31e-05	0.000361	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	6.3e-05	0.00036	CcSEcCtD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.29e-05	0.00463	CbGpPWpGaD
Fentanyl—Constipation—Valproic Acid—migraine	6.27e-05	0.000359	CcSEcCtD
Fentanyl—Pain—Valproic Acid—migraine	6.27e-05	0.000359	CcSEcCtD
Fentanyl—Erythema—Topiramate—migraine	6.27e-05	0.000359	CcSEcCtD
Fentanyl—Malnutrition—Topiramate—migraine	6.27e-05	0.000359	CcSEcCtD
Fentanyl—Discomfort—Gabapentin—migraine	6.27e-05	0.000359	CcSEcCtD
Fentanyl—Anorexia—Timolol—migraine	6.22e-05	0.000356	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.21e-05	0.00457	CbGpPWpGaD
Fentanyl—Dry mouth—Gabapentin—migraine	6.2e-05	0.000355	CcSEcCtD
Fentanyl—Flatulence—Topiramate—migraine	6.18e-05	0.000353	CcSEcCtD
Fentanyl—Tension—Topiramate—migraine	6.15e-05	0.000352	CcSEcCtD
Fentanyl—Nausea—Verapamil—migraine	6.14e-05	0.000352	CcSEcCtD
Fentanyl—Dysgeusia—Topiramate—migraine	6.14e-05	0.000351	CcSEcCtD
Fentanyl—Confusional state—Gabapentin—migraine	6.13e-05	0.000351	CcSEcCtD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.12e-05	0.0045	CbGpPWpGaD
Fentanyl—Hypotension—Timolol—migraine	6.1e-05	0.000349	CcSEcCtD
Fentanyl—OPRK1—Signaling by GPCR—RAMP1—migraine	6.09e-05	0.00448	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CALCRL—migraine	6.09e-05	0.00448	CbGpPWpGaD
Fentanyl—Nervousness—Topiramate—migraine	6.09e-05	0.000348	CcSEcCtD
Fentanyl—Anaphylactic shock—Gabapentin—migraine	6.08e-05	0.000348	CcSEcCtD
Fentanyl—Oedema—Gabapentin—migraine	6.08e-05	0.000348	CcSEcCtD
Fentanyl—Back pain—Topiramate—migraine	6.06e-05	0.000347	CcSEcCtD
Fentanyl—Feeling abnormal—Valproic Acid—migraine	6.04e-05	0.000346	CcSEcCtD
Fentanyl—Infection—Gabapentin—migraine	6.04e-05	0.000346	CcSEcCtD
Fentanyl—Muscle spasms—Topiramate—migraine	6.03e-05	0.000345	CcSEcCtD
Fentanyl—Gastrointestinal pain—Valproic Acid—migraine	6e-05	0.000343	CcSEcCtD
Fentanyl—Shock—Gabapentin—migraine	5.98e-05	0.000342	CcSEcCtD
Fentanyl—Nervous system disorder—Gabapentin—migraine	5.96e-05	0.000341	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—HTR1B—migraine	5.96e-05	0.00438	CbGpPWpGaD
Fentanyl—Thrombocytopenia—Gabapentin—migraine	5.95e-05	0.000341	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Timolol—migraine	5.95e-05	0.00034	CcSEcCtD
Fentanyl—Tachycardia—Gabapentin—migraine	5.93e-05	0.00034	CcSEcCtD
Fentanyl—Vision blurred—Topiramate—migraine	5.91e-05	0.000338	CcSEcCtD
Fentanyl—Skin disorder—Gabapentin—migraine	5.91e-05	0.000338	CcSEcCtD
Fentanyl—Insomnia—Timolol—migraine	5.91e-05	0.000338	CcSEcCtD
Fentanyl—Hyperhidrosis—Gabapentin—migraine	5.88e-05	0.000336	CcSEcCtD
Fentanyl—Tremor—Topiramate—migraine	5.87e-05	0.000336	CcSEcCtD
Fentanyl—Paraesthesia—Timolol—migraine	5.86e-05	0.000336	CcSEcCtD
Fentanyl—Urticaria—Valproic Acid—migraine	5.83e-05	0.000333	CcSEcCtD
Fentanyl—Dyspnoea—Timolol—migraine	5.82e-05	0.000333	CcSEcCtD
Fentanyl—Ill-defined disorder—Topiramate—migraine	5.82e-05	0.000333	CcSEcCtD
Fentanyl—Somnolence—Timolol—migraine	5.8e-05	0.000332	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.8e-05	0.00427	CbGpPWpGaD
Fentanyl—Abdominal pain—Valproic Acid—migraine	5.8e-05	0.000332	CcSEcCtD
Fentanyl—Body temperature increased—Valproic Acid—migraine	5.8e-05	0.000332	CcSEcCtD
Fentanyl—Anorexia—Gabapentin—migraine	5.8e-05	0.000332	CcSEcCtD
Fentanyl—Anaemia—Topiramate—migraine	5.79e-05	0.000332	CcSEcCtD
Fentanyl—Agitation—Topiramate—migraine	5.76e-05	0.00033	CcSEcCtD
Fentanyl—Dyspepsia—Timolol—migraine	5.75e-05	0.000329	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—HTR1A—migraine	5.74e-05	0.00422	CbGpPWpGaD
Fentanyl—Hypotension—Gabapentin—migraine	5.68e-05	0.000325	CcSEcCtD
Fentanyl—Decreased appetite—Timolol—migraine	5.68e-05	0.000325	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—CALCRL—migraine	5.67e-05	0.00417	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—RAMP1—migraine	5.67e-05	0.00417	CbGpPWpGaD
Fentanyl—Malaise—Topiramate—migraine	5.65e-05	0.000323	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—TAC1—migraine	5.65e-05	0.00416	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—NPS—migraine	5.65e-05	0.00416	CbGpPWpGaD
Fentanyl—Gastrointestinal disorder—Timolol—migraine	5.64e-05	0.000323	CcSEcCtD
Fentanyl—Vertigo—Topiramate—migraine	5.63e-05	0.000322	CcSEcCtD
Fentanyl—Fatigue—Timolol—migraine	5.63e-05	0.000322	CcSEcCtD
Fentanyl—Syncope—Topiramate—migraine	5.62e-05	0.000322	CcSEcCtD
Fentanyl—Leukopenia—Topiramate—migraine	5.61e-05	0.000321	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.59e-05	0.00411	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.58e-05	0.00411	CbGpPWpGaD
Fentanyl—Pain—Timolol—migraine	5.58e-05	0.00032	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—HTR1D—migraine	5.56e-05	0.00409	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR2C—migraine	5.54e-05	0.00408	CbGpPWpGaD
Fentanyl—Musculoskeletal discomfort—Gabapentin—migraine	5.54e-05	0.000317	CcSEcCtD
Fentanyl—Palpitations—Topiramate—migraine	5.54e-05	0.000317	CcSEcCtD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.51e-05	0.00406	CbGpPWpGaD
Fentanyl—Loss of consciousness—Topiramate—migraine	5.51e-05	0.000315	CcSEcCtD
Fentanyl—Insomnia—Gabapentin—migraine	5.5e-05	0.000315	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.5e-05	0.00404	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.5e-05	0.00404	CbGpPWpGaD
Fentanyl—Cough—Topiramate—migraine	5.47e-05	0.000313	CcSEcCtD
Fentanyl—Paraesthesia—Gabapentin—migraine	5.46e-05	0.000312	CcSEcCtD
Fentanyl—Convulsion—Topiramate—migraine	5.43e-05	0.000311	CcSEcCtD
Fentanyl—Dyspnoea—Gabapentin—migraine	5.42e-05	0.00031	CcSEcCtD
Fentanyl—Hypertension—Topiramate—migraine	5.41e-05	0.00031	CcSEcCtD
Fentanyl—Somnolence—Gabapentin—migraine	5.41e-05	0.000309	CcSEcCtD
Fentanyl—Hypersensitivity—Valproic Acid—migraine	5.4e-05	0.000309	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.39e-05	0.00397	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—EDNRA—migraine	5.39e-05	0.00397	CbGpPWpGaD
Fentanyl—Feeling abnormal—Timolol—migraine	5.38e-05	0.000308	CcSEcCtD
Fentanyl—Dyspepsia—Gabapentin—migraine	5.35e-05	0.000306	CcSEcCtD
Fentanyl—Gastrointestinal pain—Timolol—migraine	5.34e-05	0.000306	CcSEcCtD
Fentanyl—Arthralgia—Topiramate—migraine	5.34e-05	0.000305	CcSEcCtD
Fentanyl—Chest pain—Topiramate—migraine	5.34e-05	0.000305	CcSEcCtD
Fentanyl—Myalgia—Topiramate—migraine	5.34e-05	0.000305	CcSEcCtD
Fentanyl—Anxiety—Topiramate—migraine	5.32e-05	0.000304	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	5.3e-05	0.000303	CcSEcCtD
Fentanyl—Decreased appetite—Gabapentin—migraine	5.29e-05	0.000302	CcSEcCtD
Fentanyl—Discomfort—Topiramate—migraine	5.27e-05	0.000302	CcSEcCtD
Fentanyl—Asthenia—Valproic Acid—migraine	5.26e-05	0.000301	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Gabapentin—migraine	5.25e-05	0.0003	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.25e-05	0.00386	CbGpPWpGaD
Fentanyl—Fatigue—Gabapentin—migraine	5.24e-05	0.0003	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—HTR1B—migraine	5.23e-05	0.00384	CbGpPWpGaD
Fentanyl—Dry mouth—Topiramate—migraine	5.22e-05	0.000299	CcSEcCtD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.21e-05	0.00383	CbGpPWpGaD
Fentanyl—Pain—Gabapentin—migraine	5.2e-05	0.000298	CcSEcCtD
Fentanyl—Constipation—Gabapentin—migraine	5.2e-05	0.000298	CcSEcCtD
Fentanyl—Pruritus—Valproic Acid—migraine	5.19e-05	0.000297	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—CALCA—migraine	5.19e-05	0.00382	CbGpPWpGaD
Fentanyl—Urticaria—Timolol—migraine	5.19e-05	0.000297	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—HTR2B—migraine	5.17e-05	0.0038	CbGpPWpGaD
Fentanyl—Body temperature increased—Timolol—migraine	5.16e-05	0.000295	CcSEcCtD
Fentanyl—Abdominal pain—Timolol—migraine	5.16e-05	0.000295	CcSEcCtD
Fentanyl—Confusional state—Topiramate—migraine	5.16e-05	0.000295	CcSEcCtD
Fentanyl—OPRM1—Signaling by GPCR—RAMP1—migraine	5.15e-05	0.00379	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CALCRL—migraine	5.15e-05	0.00379	CbGpPWpGaD
Fentanyl—Oedema—Topiramate—migraine	5.12e-05	0.000293	CcSEcCtD
Fentanyl—Infection—Topiramate—migraine	5.08e-05	0.000291	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—HTR1D—migraine	5.05e-05	0.00371	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	5.04e-05	0.00371	CbGpPWpGaD
Fentanyl—Shock—Topiramate—migraine	5.03e-05	0.000288	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—HTR1A—migraine	5.03e-05	0.0037	CbGpPWpGaD
Fentanyl—Diarrhoea—Valproic Acid—migraine	5.02e-05	0.000287	CcSEcCtD
Fentanyl—Nervous system disorder—Topiramate—migraine	5.02e-05	0.000287	CcSEcCtD
Fentanyl—Feeling abnormal—Gabapentin—migraine	5.01e-05	0.000287	CcSEcCtD
Fentanyl—Thrombocytopenia—Topiramate—migraine	5.01e-05	0.000287	CcSEcCtD
Fentanyl—Tachycardia—Topiramate—migraine	4.99e-05	0.000286	CcSEcCtD
Fentanyl—Gastrointestinal pain—Gabapentin—migraine	4.97e-05	0.000285	CcSEcCtD
Fentanyl—Skin disorder—Topiramate—migraine	4.97e-05	0.000284	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—NPS—migraine	4.96e-05	0.00364	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—TAC1—migraine	4.96e-05	0.00364	CbGpPWpGaD
Fentanyl—Hyperhidrosis—Topiramate—migraine	4.95e-05	0.000283	CcSEcCtD
Fentanyl—Anorexia—Topiramate—migraine	4.88e-05	0.000279	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—HTR1D—migraine	4.88e-05	0.00359	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR2C—migraine	4.86e-05	0.00357	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR7—migraine	4.85e-05	0.00357	CbGpPWpGaD
Fentanyl—Dizziness—Valproic Acid—migraine	4.85e-05	0.000278	CcSEcCtD
Fentanyl—Urticaria—Gabapentin—migraine	4.83e-05	0.000276	CcSEcCtD
Fentanyl—Hypersensitivity—Timolol—migraine	4.81e-05	0.000275	CcSEcCtD
Fentanyl—Abdominal pain—Gabapentin—migraine	4.81e-05	0.000275	CcSEcCtD
Fentanyl—Body temperature increased—Gabapentin—migraine	4.81e-05	0.000275	CcSEcCtD
Fentanyl—Hypotension—Topiramate—migraine	4.78e-05	0.000274	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—EDNRA—migraine	4.73e-05	0.00348	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.72e-05	0.00347	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR2B—migraine	4.69e-05	0.00345	CbGpPWpGaD
Fentanyl—Asthenia—Timolol—migraine	4.68e-05	0.000268	CcSEcCtD
Fentanyl—Vomiting—Valproic Acid—migraine	4.66e-05	0.000267	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Topiramate—migraine	4.66e-05	0.000267	CcSEcCtD
Fentanyl—Insomnia—Topiramate—migraine	4.63e-05	0.000265	CcSEcCtD
Fentanyl—Rash—Valproic Acid—migraine	4.62e-05	0.000265	CcSEcCtD
Fentanyl—Dermatitis—Valproic Acid—migraine	4.62e-05	0.000264	CcSEcCtD
Fentanyl—Pruritus—Timolol—migraine	4.62e-05	0.000264	CcSEcCtD
Fentanyl—Headache—Valproic Acid—migraine	4.59e-05	0.000263	CcSEcCtD
Fentanyl—Paraesthesia—Topiramate—migraine	4.59e-05	0.000263	CcSEcCtD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.57e-05	0.00336	CbGpPWpGaD
Fentanyl—Dyspnoea—Topiramate—migraine	4.56e-05	0.000261	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—CALCA—migraine	4.55e-05	0.00335	CbGpPWpGaD
Fentanyl—Somnolence—Topiramate—migraine	4.55e-05	0.00026	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—HTR2B—migraine	4.53e-05	0.00333	CbGpPWpGaD
Fentanyl—Dyspepsia—Topiramate—migraine	4.5e-05	0.000258	CcSEcCtD
Fentanyl—Hypersensitivity—Gabapentin—migraine	4.48e-05	0.000256	CcSEcCtD
Fentanyl—Diarrhoea—Timolol—migraine	4.47e-05	0.000256	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.46e-05	0.00328	CbGpPWpGaD
Fentanyl—Decreased appetite—Topiramate—migraine	4.45e-05	0.000254	CcSEcCtD
Fentanyl—OPRK1—Signaling by GPCR—HTR1D—migraine	4.43e-05	0.00326	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR1B—migraine	4.42e-05	0.00325	CbGpPWpGaD
Fentanyl—Gastrointestinal disorder—Topiramate—migraine	4.42e-05	0.000253	CcSEcCtD
Fentanyl—Fatigue—Topiramate—migraine	4.41e-05	0.000252	CcSEcCtD
Fentanyl—Constipation—Topiramate—migraine	4.37e-05	0.00025	CcSEcCtD
Fentanyl—Pain—Topiramate—migraine	4.37e-05	0.00025	CcSEcCtD
Fentanyl—Asthenia—Gabapentin—migraine	4.36e-05	0.00025	CcSEcCtD
Fentanyl—Nausea—Valproic Acid—migraine	4.36e-05	0.000249	CcSEcCtD
Fentanyl—Dizziness—Timolol—migraine	4.32e-05	0.000247	CcSEcCtD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	4.31e-05	0.00317	CbGpPWpGaD
Fentanyl—Pruritus—Gabapentin—migraine	4.3e-05	0.000246	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—HTR7—migraine	4.26e-05	0.00313	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR1A—migraine	4.25e-05	0.00313	CbGpPWpGaD
Fentanyl—Feeling abnormal—Topiramate—migraine	4.22e-05	0.000241	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—NPS—migraine	4.19e-05	0.00308	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—TAC1—migraine	4.19e-05	0.00308	CbGpPWpGaD
Fentanyl—Gastrointestinal pain—Topiramate—migraine	4.18e-05	0.000239	CcSEcCtD
Fentanyl—Diarrhoea—Gabapentin—migraine	4.16e-05	0.000238	CcSEcCtD
Fentanyl—Vomiting—Timolol—migraine	4.15e-05	0.000238	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—HTR1D—migraine	4.12e-05	0.00303	CbGpPWpGaD
Fentanyl—Rash—Timolol—migraine	4.12e-05	0.000236	CcSEcCtD
Fentanyl—OPRK1—Signaling by GPCR—HTR2B—migraine	4.12e-05	0.00303	CbGpPWpGaD
Fentanyl—Dermatitis—Timolol—migraine	4.11e-05	0.000235	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—HTR2C—migraine	4.11e-05	0.00302	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CALCRL—migraine	4.11e-05	0.00302	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAMP1—migraine	4.11e-05	0.00302	CbGpPWpGaD
Fentanyl—Headache—Timolol—migraine	4.09e-05	0.000234	CcSEcCtD
Fentanyl—Urticaria—Topiramate—migraine	4.06e-05	0.000233	CcSEcCtD
Fentanyl—Abdominal pain—Topiramate—migraine	4.04e-05	0.000231	CcSEcCtD
Fentanyl—Body temperature increased—Topiramate—migraine	4.04e-05	0.000231	CcSEcCtD
Fentanyl—Dizziness—Gabapentin—migraine	4.02e-05	0.00023	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—EDNRA—migraine	4e-05	0.00294	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.91e-05	0.00288	CbGpPWpGaD
Fentanyl—Nausea—Timolol—migraine	3.88e-05	0.000222	CcSEcCtD
Fentanyl—Vomiting—Gabapentin—migraine	3.87e-05	0.000221	CcSEcCtD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.86e-05	0.00284	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CALCA—migraine	3.85e-05	0.00283	CbGpPWpGaD
Fentanyl—Rash—Gabapentin—migraine	3.83e-05	0.000219	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2B—migraine	3.83e-05	0.00282	CbGpPWpGaD
Fentanyl—Dermatitis—Gabapentin—migraine	3.83e-05	0.000219	CcSEcCtD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	3.82e-05	0.00281	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	3.82e-05	0.00281	CbGpPWpGaD
Fentanyl—Headache—Gabapentin—migraine	3.81e-05	0.000218	CcSEcCtD
Fentanyl—Hypersensitivity—Topiramate—migraine	3.77e-05	0.000216	CcSEcCtD
Fentanyl—OPRM1—Signaling by GPCR—HTR1D—migraine	3.74e-05	0.00275	CbGpPWpGaD
Fentanyl—Asthenia—Topiramate—migraine	3.67e-05	0.00021	CcSEcCtD
Fentanyl—Pruritus—Topiramate—migraine	3.62e-05	0.000207	CcSEcCtD
Fentanyl—Nausea—Gabapentin—migraine	3.61e-05	0.000207	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—RAMP1—migraine	3.6e-05	0.00265	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CALCRL—migraine	3.6e-05	0.00265	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR7—migraine	3.6e-05	0.00265	CbGpPWpGaD
Fentanyl—Diarrhoea—Topiramate—migraine	3.5e-05	0.0002	CcSEcCtD
Fentanyl—OPRM1—Signaling by GPCR—HTR2B—migraine	3.48e-05	0.00256	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR2A—migraine	3.4e-05	0.0025	CbGpPWpGaD
Fentanyl—Dizziness—Topiramate—migraine	3.38e-05	0.000194	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—HTR1B—migraine	3.37e-05	0.00248	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.31e-05	0.00243	CbGpPWpGaD
Fentanyl—Vomiting—Topiramate—migraine	3.25e-05	0.000186	CcSEcCtD
Fentanyl—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	3.25e-05	0.00239	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR1A—migraine	3.24e-05	0.00239	CbGpPWpGaD
Fentanyl—Rash—Topiramate—migraine	3.23e-05	0.000185	CcSEcCtD
Fentanyl—Dermatitis—Topiramate—migraine	3.22e-05	0.000184	CcSEcCtD
Fentanyl—Headache—Topiramate—migraine	3.2e-05	0.000183	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—TAC1—migraine	3.19e-05	0.00235	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—NPS—migraine	3.19e-05	0.00235	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR2C—migraine	3.13e-05	0.0023	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR1B—migraine	3.06e-05	0.00225	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—EDNRA—migraine	3.05e-05	0.00224	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAMP1—migraine	3.04e-05	0.00224	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CALCRL—migraine	3.04e-05	0.00224	CbGpPWpGaD
Fentanyl—Nausea—Topiramate—migraine	3.04e-05	0.000174	CcSEcCtD
Fentanyl—OPRD1—Signaling Pathways—HTR1D—migraine	2.98e-05	0.00219	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR2A—migraine	2.98e-05	0.00219	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR1B—migraine	2.95e-05	0.00217	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR1A—migraine	2.94e-05	0.00217	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CALCA—migraine	2.93e-05	0.00216	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—TAC1—migraine	2.9e-05	0.00213	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—NPS—migraine	2.9e-05	0.00213	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR2C—migraine	2.84e-05	0.00209	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR1A—migraine	2.84e-05	0.00209	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—TAC1—migraine	2.8e-05	0.00206	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—NPS—migraine	2.8e-05	0.00206	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2B—migraine	2.77e-05	0.00204	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EDNRA—migraine	2.77e-05	0.00203	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR2C—migraine	2.75e-05	0.00202	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR7—migraine	2.74e-05	0.00202	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.73e-05	0.00201	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR1B—migraine	2.68e-05	0.00197	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—EDNRA—migraine	2.67e-05	0.00196	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CALCA—migraine	2.66e-05	0.00196	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR1D—migraine	2.62e-05	0.00192	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR1A—migraine	2.58e-05	0.0019	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CALCA—migraine	2.57e-05	0.00189	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—TAC1—migraine	2.54e-05	0.00187	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—NPS—migraine	2.54e-05	0.00187	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR2A—migraine	2.52e-05	0.00185	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR1B—migraine	2.5e-05	0.00184	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR2C—migraine	2.49e-05	0.00183	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR7—migraine	2.49e-05	0.00183	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LRP1—migraine	2.44e-05	0.0018	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2B—migraine	2.43e-05	0.00179	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EDNRA—migraine	2.43e-05	0.00178	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR7—migraine	2.41e-05	0.00177	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR1A—migraine	2.4e-05	0.00177	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CACNA1A—migraine	2.37e-05	0.00174	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—TAC1—migraine	2.37e-05	0.00174	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—NPS—migraine	2.37e-05	0.00174	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CALCA—migraine	2.34e-05	0.00172	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2C—migraine	2.32e-05	0.00171	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR1B—migraine	2.27e-05	0.00167	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—EDNRA—migraine	2.26e-05	0.00166	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR1D—migraine	2.21e-05	0.00163	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR7—migraine	2.18e-05	0.00161	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR1A—migraine	2.18e-05	0.00161	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CALCA—migraine	2.17e-05	0.0016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—TAC1—migraine	2.15e-05	0.00158	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—NPS—migraine	2.15e-05	0.00158	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LRP1—migraine	2.14e-05	0.00157	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR2C—migraine	2.11e-05	0.00155	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2B—migraine	2.05e-05	0.00151	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EDNRA—migraine	2.05e-05	0.00151	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.05e-05	0.0015	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR7—migraine	2.03e-05	0.0015	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TNF—migraine	2.01e-05	0.00148	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CALCA—migraine	1.97e-05	0.00145	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR2A—migraine	1.92e-05	0.00141	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH4—migraine	1.87e-05	0.00138	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR7—migraine	1.85e-05	0.00136	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LRP1—migraine	1.81e-05	0.00133	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR1B—migraine	1.81e-05	0.00133	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR2A—migraine	1.74e-05	0.00128	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR1A—migraine	1.74e-05	0.00128	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CACNA1A—migraine	1.71e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NPS—migraine	1.71e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TAC1—migraine	1.71e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PGR—migraine	1.71e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR2A—migraine	1.68e-05	0.00124	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2C—migraine	1.68e-05	0.00124	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH4—migraine	1.64e-05	0.00121	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EDNRA—migraine	1.63e-05	0.0012	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH3—migraine	1.59e-05	0.00117	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR1B—migraine	1.58e-05	0.00117	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CALCA—migraine	1.57e-05	0.00116	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR2A—migraine	1.53e-05	0.00113	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR1A—migraine	1.53e-05	0.00112	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TAC1—migraine	1.5e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NPS—migraine	1.5e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PGR—migraine	1.5e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2C—migraine	1.47e-05	0.00108	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR7—migraine	1.47e-05	0.00108	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EDNRA—migraine	1.43e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2A—migraine	1.42e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH3—migraine	1.4e-05	0.00103	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH4—migraine	1.39e-05	0.00102	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CALCA—migraine	1.38e-05	0.00101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR1B—migraine	1.34e-05	0.000985	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CACNA1A—migraine	1.29e-05	0.000951	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR2A—migraine	1.29e-05	0.000951	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR7—migraine	1.29e-05	0.000949	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR1A—migraine	1.29e-05	0.000948	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TAC1—migraine	1.27e-05	0.000934	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PGR—migraine	1.27e-05	0.000934	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NPS—migraine	1.27e-05	0.000934	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFBR2—migraine	1.27e-05	0.000932	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2C—migraine	1.25e-05	0.000916	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EDNRA—migraine	1.21e-05	0.000891	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH3—migraine	1.18e-05	0.000868	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CALCA—migraine	1.17e-05	0.000858	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFBR2—migraine	1.11e-05	0.000817	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR7—migraine	1.09e-05	0.000802	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2A—migraine	1.03e-05	0.000758	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	9.91e-06	0.000729	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFBR2—migraine	9.39e-06	0.000691	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ESR1—migraine	9.15e-06	0.000673	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2A—migraine	9.04e-06	0.000665	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ESR1—migraine	8.02e-06	0.00059	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CACNA1A—migraine	7.97e-06	0.000586	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—migraine	7.84e-06	0.000577	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2A—migraine	7.64e-06	0.000562	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—migraine	6.78e-06	0.000499	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—migraine	5.67e-06	0.000417	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—migraine	4.28e-06	0.000315	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—migraine	2.64e-06	0.000194	CbGpPWpGaD
